Literature DB >> 29229610

Follow-up imaging after nephrectomy for cancer in Canada: urologists' compliance with guidelines. An observational study.

Alice Dragomir1, Armen Aprikian1, Anil Kapoor1, Antonio Finelli1, Frédéric Pouliot1, Ricardo Rendon1, Peter C Black1, Ronald Moore1, Rodney H Breau1, Jun Kawakami1, Darrell Drachenberg1, Jean-Baptiste Lattouf1, Simon Tanguay1.   

Abstract

BACKGROUND: Surgical tumour removal remains the preferred treatment for most patients with renal cell carcinoma, and many medical associations have proposed guidelines for the optimal surveillance of patients following surgery. This study evaluated the adherence of Canadian urologists to the follow-up guidelines proposed by the Canadian Urological Association (CUA) in 2009.
METHODS: The study cohort was identified from the Canadian Kidney Cancer Information System, a prospectively populated database from 15 academic institutions in 6 Canadian provinces: British Colombia, Alberta, Manitoba, Ontario, Quebec and Nova Scotia. A total of 1982 patients who underwent radical or partial nephrectomy for stage pT1-3N0M0 renal cancer between January 2011 and June 2016 were included in the cohort. Numbers of abdominal and chest imaging tests performed during the follow-up period were captured and compared with the 2009 CUA guidelines. The level of compliance was measured by means of weighted κ and Pearson correlation statistics. Multivariate logistic regression was used to evaluate factors associated with noncompliance (under- or overtesting) in the postoperative surveillance period.
RESULTS: Of the 1982 patients, 1380 had stage pT1 disease, 164 had stage pT2 disease, and 438 had stage pT3 disease. There was incongruent adherence to the CUA surveillance guidelines, with a ratio of observed to recommended tests of 0.71 and 2.27 for chest and abdominal imaging, respectively. Overall, moderate correlation between observed and recommended tests was observed, with the highest value found for abdominal imaging in the pT3 group (κ = 0.59 [95% confidence interval 0.52-0.66]). Patients who underwent radical nephrectomy and those who presented with a higher stage of the disease were less likely to receive fewer chest imaging tests than recommended, and those with stage pT2 disease, those with stage pT3 disease, those with conventional clear cell renal cell carcinoma and those with a low-risk histologic type had an increased risk of undertesting.
INTERPRETATION: In the 6 Canadian provinces, there are large differences between guidelines and clinical practice in imaging surveillance after nephrectomy for renal cell carcinoma. Better adherence to clinical guidelines could improve optimization of health care services. Copyright 2017, Joule Inc. or its licensors.

Entities:  

Year:  2017        PMID: 29229610      PMCID: PMC5741415          DOI: 10.9778/cmajo.20170005

Source DB:  PubMed          Journal:  CMAJ Open        ISSN: 2291-0026


  13 in total

1.  Follow-up guidelines after radical or partial nephrectomy for localized and locally advanced renal cell carcinoma.

Authors:  Wassim Kassouf; Robert Siemens; Christopher Morash; Louis Lacombe; Michael Jewett; Larry Goldenberg; Joseph Chin; Michael Chetner; Christopher G Wood; Simon Tanguay; Armen G Aprikian
Journal:  Can Urol Assoc J       Date:  2009-02       Impact factor: 1.862

2.  Limited use of surveillance imaging following nephrectomy for renal cell carcinoma.

Authors:  Eric H Kim; Joel M Vetter; Adrienne N Kuxhausen; Joseph B Song; Gurdarshan S Sandhu; Seth A Strope
Journal:  Urol Oncol       Date:  2015-12-22       Impact factor: 3.498

3.  Patterns of surveillance imaging after nephrectomy in the Medicare population.

Authors:  Michael A Feuerstein; Coral L Atoria; Laura C Pinheiro; William C Huang; Paul Russo; Elena B Elkin
Journal:  BJU Int       Date:  2015-06-22       Impact factor: 5.588

Review 4.  Efficacy and safety of nephron-sparing surgery.

Authors:  Hein Van Poppel
Journal:  Int J Urol       Date:  2010-04       Impact factor: 3.369

5.  Surgical management of stage T1 renal tumours at Canadian academic centres.

Authors:  Luke T Lavallée; Simon Tanguay; Michael A Jewett; Lori Wood; Anil Kapoor; Ricardo A Rendon; Ronald B Moore; Louis Lacombe; Jun Kawakami; Stephen E Pautler; Darrel E Drachenberg; Peter C Black; Jean-Baptiste Lattouf; Christopher Morash; Ilias Cagiannos; Zhihui Liu; Rodney H Breau
Journal:  Can Urol Assoc J       Date:  2015 Mar-Apr       Impact factor: 1.862

Review 6.  Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease.

Authors:  Nicolette K Janzen; Hyung L Kim; Robert A Figlin; Arie S Belldegrun
Journal:  Urol Clin North Am       Date:  2003-11       Impact factor: 2.241

7.  The natural history of renal function after surgical management of renal cell carcinoma: Results from the Canadian Kidney Cancer Information System.

Authors:  Ross Mason; Anil Kapoor; Zhihui Liu; Olli Saarela; Simon Tanguay; Michael Jewett; Antonio Finelli; Louis Lacombe; Jun Kawakami; Ronald Moore; Christopher Morash; Peter Black; Ricardo A Rendon
Journal:  Urol Oncol       Date:  2016-06-22       Impact factor: 3.498

8.  Nephron-sparing surgery versus radical nephrectomy in the treatment of intracapsular renal cell carcinoma up to 7cm.

Authors:  Alessandro Antonelli; Alberto Cozzoli; Maria Nicolai; Danilo Zani; Tiziano Zanotelli; Laura Perucchini; Sergio Cosciani Cunico; Claudio Simeone
Journal:  Eur Urol       Date:  2007-11-20       Impact factor: 20.096

9.  Disease progression and kidney function after partial vs. radical nephrectomy for T1 renal cancer.

Authors:  Connor M Forbes; Ricardo A Rendon; Antonio Finelli; Anil Kapoor; Ronald B Moore; Rodney H Breau; Louis Lacombe; Jun Kawakami; Darrel E Drachenberg; Stephen E Pautler; Michael M A Jewett; Olli Saarela; Zhihui Liu; Simon Tanguay; Peter C Black
Journal:  Urol Oncol       Date:  2016-07-14       Impact factor: 3.498

10.  Follow-up for Clinically Localized Renal Neoplasms: AUA Guideline.

Authors:  Sherri M Donat; Mireya Diaz; Jay Todd Bishoff; Jonathan A Coleman; Philipp Dahm; Ithaar H Derweesh; S Duke Herrell; Susan Hilton; Eric Jonasch; Daniel W Lin; Victor E Reuter; Sam S Chang
Journal:  J Urol       Date:  2013-05-07       Impact factor: 7.450

View more
  1 in total

1.  Pathological and clinical features of multiple cancers and lung adenocarcinoma: a multicentre study.

Authors:  Pietro Bertoglio; Luigi Ventura; Vittorio Aprile; Maria Angela Cattoni; Dania Nachira; Filippo Lococo; Maria Rodriguez Perez; Francesco Guerrera; Fabrizio Minervini; Letizia Gnetti; Alessandra Lenzini; Francesca Franzi; Giulia Querzoli; Guido Rindi; Salvatore Bellafiore; Federico Femia; Giuseppe Salvatore Bogina; Diana Bacchin; Peter Kestenholz; Enrico Ruffini; Massimiliano Paci; Stefano Margaritora; Andrea Selenito Imperatori; Marco Lucchi; Luca Ampollini; Alberto Claudio Terzi
Journal:  Interact Cardiovasc Thorac Surg       Date:  2022-06-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.